SE434644B - Analogiforfarande for framstellning av 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2 dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat - Google Patents

Analogiforfarande for framstellning av 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2 dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat

Info

Publication number
SE434644B
SE434644B SE7708142A SE7708142A SE434644B SE 434644 B SE434644 B SE 434644B SE 7708142 A SE7708142 A SE 7708142A SE 7708142 A SE7708142 A SE 7708142A SE 434644 B SE434644 B SE 434644B
Authority
SE
Sweden
Prior art keywords
tenoyl
furoyl
pyrrolo
pyrrole
dihydro
Prior art date
Application number
SE7708142A
Other languages
English (en)
Swedish (sv)
Other versions
SE7708142L (sv
Inventor
J M Muchowski
A F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,283 external-priority patent/US4087539A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7708142L publication Critical patent/SE7708142L/xx
Publication of SE434644B publication Critical patent/SE434644B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7708142A 1976-07-14 1977-07-13 Analogiforfarande for framstellning av 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2 dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat SE434644B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70485776A 1976-07-14 1976-07-14
US05/771,283 US4087539A (en) 1976-07-14 1977-02-23 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof

Publications (2)

Publication Number Publication Date
SE7708142L SE7708142L (sv) 1978-01-15
SE434644B true SE434644B (sv) 1984-08-06

Family

ID=27107392

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708142A SE434644B (sv) 1976-07-14 1977-07-13 Analogiforfarande for framstellning av 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2 dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat

Country Status (26)

Country Link
JP (1) JPS539789A (ko)
AR (1) AR218631A1 (ko)
AU (1) AU513385B2 (ko)
CA (1) CA1100140A (ko)
CH (2) CH651045A5 (ko)
CS (1) CS208724B2 (ko)
DE (1) DE2731662A1 (ko)
DK (1) DK152652C (ko)
ES (2) ES460705A1 (ko)
FI (1) FI63407C (ko)
FR (1) FR2361396A1 (ko)
GB (1) GB1554076A (ko)
GR (1) GR61607B (ko)
HK (1) HK17581A (ko)
IE (1) IE45302B1 (ko)
IL (1) IL52492A (ko)
IT (1) IT1117314B (ko)
MY (1) MY8100371A (ko)
NL (1) NL7707652A (ko)
NO (1) NO147563C (ko)
NZ (1) NZ184611A (ko)
PL (1) PL111408B1 (ko)
PT (1) PT66779B (ko)
SE (1) SE434644B (ko)
SU (2) SU664566A3 (ko)
YU (2) YU43157B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
JPS5910589A (ja) * 1982-06-10 1984-01-20 メルク エンド カムパニー インコーポレーテツド 抗炎症剤および鎮痛剤として新規な5−(ピロ−ル−2−オイル)−1,2−ジヒドロ−3H−ピロロ〔1,2−a〕ピロ−ル誘導体
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds

Also Published As

Publication number Publication date
CH644861A5 (en) 1984-08-31
IL52492A (en) 1981-06-29
DE2731662A1 (de) 1978-01-19
GB1554076A (en) 1979-10-17
IE45302B1 (en) 1982-07-28
FR2361396A1 (fr) 1978-03-10
YU43157B (en) 1989-04-30
SU793400A3 (ru) 1980-12-30
JPS6254110B2 (ko) 1987-11-13
FI63407B (fi) 1983-02-28
GR61607B (en) 1978-12-02
FR2361396B1 (ko) 1981-11-27
DK152652C (da) 1988-09-12
NO772493L (no) 1978-01-17
AU2697677A (en) 1979-01-18
SU664566A3 (ru) 1979-05-25
CH651045A5 (en) 1985-08-30
DE2731662C2 (ko) 1989-11-09
PT66779B (fr) 1978-12-18
NO147563C (no) 1983-05-18
ES460705A1 (es) 1979-10-01
MY8100371A (en) 1981-12-31
YU47583A (en) 1984-06-30
YU43156B (en) 1989-04-30
NL7707652A (nl) 1978-01-17
SE7708142L (sv) 1978-01-15
PT66779A (fr) 1977-08-01
DK152652B (da) 1988-04-05
AU513385B2 (en) 1980-11-27
IE45302L (en) 1978-01-14
HK17581A (en) 1981-05-08
IT1117314B (it) 1986-02-17
PL111408B1 (en) 1980-08-30
JPS539789A (en) 1978-01-28
PL199602A1 (pl) 1979-01-29
CS208724B2 (en) 1981-09-15
AR218631A1 (es) 1980-06-30
CA1100140A (en) 1981-04-28
DK307677A (da) 1978-01-15
NZ184611A (en) 1979-03-28
YU47683A (en) 1984-04-30
FI772154A (ko) 1978-01-15
IL52492A0 (en) 1977-10-31
NO147563B (no) 1983-01-24
ES470213A1 (es) 1979-09-16
FI63407C (fi) 1983-06-10

Similar Documents

Publication Publication Date Title
ZA774239B (en) 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl)-and 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives and process for the production thereof
SE7803549L (sv) 5-(2-pyrroyl)-1,2-dihydro-3h-pyrrolo (1,2-a)-pyrrol-1-karbonsyraderivat och sett att framstella desamma
DK160279C (da) Analogifremgangsmaade til fremstilling af 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-on-derivater
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO154344C (no) Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO154167C (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme flavanforbindelser.
NO147913C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
SE426833B (sv) Forfarande for framstellning av nya gona-4,9(10)-diener
SE434643B (sv) Analogiforfarande for framstellning av 5-aroyl-1,2-dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat
NO773470L (no) Fremgangsmaate til fremstilling av 2,4,6,tri-(3,5-ditertiaert butyl-4-hydroksybenzyl) mesitylen
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE431334B (sv) Analogiforfarande for framstellning av racemiska eller optiskt aktiva, kondenserade pyrimidinderivat
SE434644B (sv) Analogiforfarande for framstellning av 5-(2-furoyl)-, 5-(2-tenoyl)-, 5-(3-furoyl)- och 5-(3-tenoyl)-1,2 dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-karbonsyraderivat
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE422462B (sv) Analogiforfarande for framstellning av 6-aryl-pyrolo-(1,2-a)imidazol-derivat
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
SE7700533L (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat
FI782517A (fi) Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner
NO147340C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive octahydro-indolo(2,3-a) kinoliziner
SE420411B (sv) Analogiforfarande for framstellning av indolo (2,3-a)kinolizidinderivat
SE432594B (sv) Analogiforfarande for framstellning av pyrido (1,2-a)pyrimidinderivat
NO774262L (no) Fremgangsmaate til fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-1-piperazinyl) kinazolin med blodtrykksenkende virkning

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7708142-0

Effective date: 19910211

Format of ref document f/p: F